Health & Biotech
Prescient doses first patient in Phase 2a cancer trial
Trajan reaffirms FY25 guidance despite geopolitical and market pressures
As AI rewires microbiology, Clever Culture’s lab tech is catching Big Pharma’s eye
Health Check: Aroa’s ‘hero’ product propels the wound management house back into black
Aroa rides on the sheep’s back with maiden profit in FY25
ReNerve gains market approval in Bahrain for NervAlign nerve cuff
Health Check: Fisher & Paykel Healthcare defies the hospital cost crunch with record revenue
Biocurious: Forgotten trans-Tasman ‘small Big Pharma’ takes on the big boys with a niche strategy
Health Check: Optiscan perfects ‘dial a pathologist’ platform; 4D Medical probes further FDA approval
Dr Boreham’s Crucible: This pancreatic cancer tackler has faith its ‘good science will prevail’
Recce secures Chinese patent as it targets superbugs with new anti-infectives
Health Check: The endo-metriosis? Proteomics is on the case
Rhythm upbeat after putting next-gen bowel cancer test kit through its paces
Scott Power: ASX health stocks rise with capital raisings in full swing
Trajan’s strengthening European and UK footprint featured at Europe’s largest investor event
Health Check: ‘Forgotten’ drug maker AFT Pharma aims high with revenue
Compumedics inks $1m deal with leading researchers for sleep monitoring device
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
